Company intelligence

TARA

Protara Therapeutics, Inc. · NASDAQ · Healthcare

Price$2.50+0.60% · +$0.02

Market cap147.44MEquity value

P / E-1.9Trailing ratio

Volume303.53KLatest session

Market data

TARA price chart

TradingView

Related signals

1 min delayed

Browse public TARA signals with their source context and measured market impact. Open any signal for its permanent analysis page.

TARAMay 15, 2026-7.88% since signal

TARA-002 Shows Promising Efficacy Despite Bearish Share Pressure

Protara Therapeutics presented updated findings from the ADVANCED-2 study, highlighting a 72.4% complete response rate for TARA-002 in NMIBC patients. Despite these positive results, TARA shares are experiencing bearish trends, suggesting potential market overreaction or profit-taking ahead of upcoming registrational studies in late 2026.

View signal analysis

TARADec 5, 2024-20.46% since signal

Why Is Protara Therapeutics Stock Skyrocketing Over 100% On Thursday?

Protara's TARA-002 showed promising Phase 2 trial results in NMIBC patients. Complete response rate reached 72% at six months in BCG-Unresponsive patients. No serious adverse events reported, indicating favorable safety profile. Results to be featured at a key medical conference for broader visibility. Stock surged 119% following positive trial data release.

View signal analysis

Research